'Shin Godzilla' Is Receiving a North American 4K Remastered Theatrical Re-Release
Shin Godzillais returning to North American theaters for a 4K remastered re-release.
Varietyreports that Gkids acquired the North American distribution rights to Hideaki Anno's 2016 film.Shin Godzillais now slated to hit the big screen in its 4K glory, complete with its original Japanese language, subtitles and restored text cards. This will mark the first release of aGodzillatitle since Toho acquired Gkids last year.
Gkids President David Jesteadt said, 'With an incredibly timely story of people struggling to work together to stop imminent destruction, backed by some of the most explosive action scenes the franchise has ever seen, 'Shin Godzilla' is a modern masterpiece. We are honored to play a part in bringing the film back for American fans, better than ever.'
''Shin Godzilla' marked the first Japanese-produced Godzilla film since the release of 'Godzilla Final Wars' in 2004,' Keiji Ota, Toho's chief Godzilla officer, added. 'Upon its release, it became a social phenomenon in Japan, playing a pivotal role in reviving the Godzilla franchise after a 12-year hiatus, and we're thrilled to bring this landmark film back to the big screen in North America.'
Ota continued, 'For some, this will be their first time experiencing it — and there's no better way to feel the overwhelming presence, power, and terror of Godzilla than in a theater. Enjoy the film!'
Shin Godzillagrossed $79 million USD worldwide. It was once the highest-grossing Japanese-producedGodzillatitle, but was overthrown byGodzilla Minus Onein 2023.
Shin Godzillahits North American theaters on August 14.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
U.S. Leads North America Syringe Infusion Pumps Market Amid Rising Hospitalizations and Chronic Diseases
The North America Syringe Infusion Pumps Market is projected to grow from USD 645.1 million in 2024 to USD 1.04 billion by 2030, at a CAGR of 8.40%. Key drivers include an increase in chronic diseases and surgeries, technological advancements, and the expansion of home healthcare. The market is bolstered by favorable regulations and major regional growth. North American Syringe Infusion Pumps Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report by Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), End-use (Hospitals, Homecare), Country with Growth Forecasts, 2025-2030" report has been added to North America Syringe Infusion Pumps Market was valued at USD 645.1 million in 2024, and is projected to reach USD 1.04 billion by 2030, rising at a CAGR of 8.40%. The market is experiencing substantial growth driven by the increasing prevalence of chronic diseases, affecting approximately six in ten adults and necessitating precise, continuous medication delivery for conditions such as cancer and diabetes. The rising number of surgical procedures and ICU admissions further amplifies demand for these pumps, crucial for delivering anesthetics and critical care medications. This is especially true considering the projected increase in U.S. hospitalizations from 36 million in 2025 to 40 million by advancements in smart infusion technologies, including Dose Error Reduction Systems (DERS) and EHR compatibility, are pivotal in enhancing medication safety and efficiency, as North America leads in their adoption. The expanding home healthcare and ambulatory care sectors, fueled by an aging population and cost-containment strategies, are increasing the demand for portable, user-friendly syringe pumps for safe medication delivery outside hospitals. Favorable regulatory environments and reimbursement policies further support the sustained growth and innovation within the America Syringe Infusion Pumps Market Report Highlights: Pediatrics/neonatology held the largest revenue share of over 25% in 2024, owing to the critical need for precise drug delivery for newborns and infants, coupled with advancements in safety technologies and NICU/PICU investments The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period Market growth is fueled by the critical need for precise syringe pump delivery of potent drugs, supported by safety features, and the increasing number of cancer cases. Hospitals dominated the market with around 40.0% of the total revenue share in 2024 due to high demand for precise drug delivery in critical care and diverse applications. Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period. The U.S. dominated the North American syringe infusion pumps market, supported by the high prevalence of chronic diseases and growing national healthcare expenditure. Companies Featured The major companies featured in this North America Syringe Infusion Pumps market report include: Baxter B. Braun Medical Inc. Fresenius Kabi AG ICU Medical, Inc. Micrel Medical Devices SA Boston Scientific Corporation BD Terumo Corporation Moog Inc. IRadimed Corporation CODAN Companies ACROMED Key Attributes: Report Attribute Details No. of Pages 80 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $645.1 Million Forecasted Market Value (USD) by 2030 $1040 Million Compound Annual Growth Rate 8.4% Regions Covered North America Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. North America Syringe Infusion Pumps Market Variables, Trends & Scope3.1. Market Lineage Outlook3.2. Market Dynamics3.3. North America Syringe Infusion Pumps Market Analysis Tools3.3.1. Industry Analysis - Porter's3.3.2. PESTEL AnalysisChapter 4. North America Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis4.1. Disease Indication Segment Dashboard4.2. North America Syringe Infusion Pumps Market: Disease Indication Movement Analysis4.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)4.4. Chemotherapy4.5. Diabetes4.6. Gastroenterology4.7. Analgesia/Pain Management4.8. Pediatrics/Neonatology4.9. Hematology4.10. OthersChapter 5. North America Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis5.1. End Use Segment Dashboard5.2. North America Syringe Infusion Pumps Market: End Use Movement Analysis5.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)5.4. Hospitals5.5. Homecare5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)Chapter 6. North America Syringe Infusion Pumps Market: Country Estimates & Trend Analysis6.1. Country Market Dashboard6.2. Country Market Share Analysis, 2024 & 20306.3. North America Syringe Infusion Pumps Market by country: Key Takeaways6.4. U.S.6.5. Canada6.6. MexicoChapter 7. Competitive Landscape7.1. Recent Developments & Impact Analysis, By Key Market Participants7.2. Company/Competition Categorization7.3. Vendor Landscape7.3.1. Key company heat map analysis, 20247.4. Company Profiles Baxter B. Braun Medical Inc. Fresenius Kabi AG ICU Medical, Inc. Micrel Medical Devices SA Boston Scientific Corporation BD Terumo Corporation Moog Inc. IRadimed Corporation CODAN Companies ACROMED For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Syringe Infusion Pumps Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hypebeast
8 hours ago
- Hypebeast
Stellantis Revives SRT Performance Division Under Tim Kuniskis
Summary Stellantishas officially revived its iconic Street and Racing Technology (SRT) division, appointing Tim Kuniskis to lead the reborn performance arm while also taking on a newly created role overseeing American brands and North America marketing and retail strategy. Kuniskis will retain his position as CEO ofRam, and continue shaping the performance future ofChrysler,Dodge,Jeep, and Ram. The return of SRT signals a renewed focus on high-performance engineering across Stellantis' American brands. 'We're getting the band back together,' said Kuniskis, who emphasized assembling top talent in powertrain and vehicle dynamics to deliver the kind of power, handling and innovation that defines the SRT name. The division will also oversee Direct Connection, North American motorsports efforts and initiatives like Ram's return to the NASCAR Truck Series in 2026. With this move, Stellantis aims to unify its performance strategy and reignite enthusiasm among loyal fans. According to Stellantis COO Antonio Filosa, the company is counting on Kuniskis' 'strategic mindset and competitive spirit' to build deeper connections with customers through bold performance products and experiences.
Yahoo
12 hours ago
- Yahoo
F1 American Explosion: Another Record Falls in Canada, Proving the Hype is Real
There are a growing number of F1 fanatics in the United States, with more and more of you climbing on board each week. If you've been following the Formula 1 season, you know the buzz around its growth in the U.S. is palpable. Well, guess what? The latest television viewership numbers from the Canadian Grand Prix are in, and they're not just good – they're record-breaking, adding yet another bullet point to the undeniable story of F1's booming popularity stateside. Advertisement Related: Final F1 movie trailer ignites anticipation ahead of June release Canadian Grand Prix sets new record for viewers in the U.S. Credit: David Kirouac-Imagn Images The recent race in Montreal, broadcast live on ABC on Sunday, June 15, pulled in an astonishing 1.9 million viewers for the race-only portion. That's not just a significant number, it's the largest audience ever for the Canadian Grand Prix on U.S. television, even surpassing last year's record of 1.8 million. And for those tracking the future of the sport, the demographic numbers are equally encouraging, with 854,000 viewers in the crucial 18-49 age bracket tuning in. Even Saturday's qualifying session on ESPN2 snagged a respectable 593,000 viewers. This success wasn't a fluke. The favorable North American time slot, kicking off at 2 PM Eastern Daylight Time, meant many U.S. fans could watch the high-octane action in prime daylight hours, without setting early alarms or staying up late. This accessible timing, combined with the exciting on-track action, clearly resonated with American audiences. Advertisement Related: F1 Growth Surge: How women are driving the sport forward F1 growth in the U.S. continues to soar Credit: Sam Navarro-Imagn Images This isn't an isolated incident. Out of nine F1 races so far this season, all but one have seen year-over-year viewership increases, and five of them – Australia, China, Monaco, Spain, and Canada – have set event records. The Monaco Grand Prix alone drew the third-largest live audience ever for a Formula 1 race on U.S. television. Overall, F1 races are now averaging a robust 1.3 million viewers across ESPN, ESPN2, and ABC, a solid 6% jump year-over-year for the season-to-date. The younger 18-49 demographic is seeing even steeper growth, up 13% over the season-to-date average. Advertisement The momentum is undeniable. With the Austrian Grand Prix up next on June 29, F1 continues to cement its place as a major player in the American sports landscape. Related: F1 vs. IndyCar: Key differences explained ahead of Indianapolis 500 and Monaco Grand Prix Related Headlines
